THE VALUE OF ULTRASOUND CRITERIA IN THE DIAGNOSIS OF POLYCYSTIC OVARIAN MORPHOLOGY
Main Article Content
Abstract
Polycystic ovary syndrome (PCOS) is one of the most commonly observed diseases associated with endocrine disorders in women of childbearing age. The prevalence of PCOS is associated with the assessment of the criteria used to recognize this syndrome and the characteristics of the population sample. Early diagnosis of PCOS plays a key role in treating symptoms, improving quality of life and identifying fertility problems, and, in the long term, including metabolic, cardiovascular and psychosocial issues. It remains relevant to search for clear, specific markers of PCOS, allowing the detection of the disease in the early stages of its development. Diagnosis of polycystic ovary syndrome, including with the help of ultrasound, in women of reproductive age is of great social and medical importance. Ultrasonographic findings for the diagnosis of PCOS should be interpreted in conjunction with hormonal studies, in particular with serum AMH levels. Early recognition and an individual approach to the management of patients with PCOS are necessary for the selection of treatment, predicting the course of the disease.
Downloads
Article Details
Issue
Section
Author Biographies
Елена Николаевна Кравченко, Omsk State Medical University, Omsk
Doctor of medical sciences, professor, head of chair of obstetrics and gynecology
Елена Юрьевна Хомутова, Omsk State Medical University
doctor of medical sciences, docent, head of the department of radiation diagnosticsЭльмира Наильевна Енгуразова, Clinical diagnostic center «Ultramed», Omsk
doctor of ultrasound diagnosticsReferences
Azziz R. Polycystic Ovary Syndrome. Obstet Gynecol. 2018; 132(2): 321-336. doi: 10.1097/AOG.0000000000002698
Meier RK. Polycystic Ovary Syndrome. Nurs Clin North Am. 2018; 53(3): 407-420. doi: 10.1016/j.cnur.2018.04.008
Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012; 27(10): 3067-3073
Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol. 2008; 139(l): 59-64
Huraseva AB, Konoplya AA, Akkuan AA, Brimpong BB, Svyatchenko KS. An overview of the leading symptoms and phenotypes of polycystic ovary syndrome among different races. Regional'nyj vestnik. 2018; 4(13): 2-5. Russian (Хурасева А.Б., Конопля А.А., Аккуан А.А., Бримпонг Б.Б., Святченко К.С. Обзор ведущих симптомов и фенотипов синдрома поликистозных яичников среди различных рас //Региональный вестник. 2018. № 4(13). С. 2-5)
Sosnova EA. Polycystic ovary syndrome. Snegirev Archives of Obstetrics and Gynecology. 2016; 3(3): 116-129. Russian (Соснова Е.А. Синдром поликистозных яичников //Архив акушерства и гинекологии им. В.Ф. Снегирева. 2016. Т. 3, № 3. С. 116-129.) https://doi.org/10.18821/2313-8726-2016-3-3-116-129
Nazarenko TA, Mishieva NG. Infertility and age: ways to solve the problem. 2nd ed. М., 2014. Russian (Назаренко Т.А., Мишиева Н.Г. Бесплодие и возраст: пути решения проблемы. 2-е изд. М., 2014)
De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016; 14(1): 38. https://doi. org/10.1186/s12958-016-0173-x
Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5): 270-284. doi: 10.1038/nrendo.2018.24
Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015; 36(5): 487-525. https://doi. org/10.1210/er.2015-1018
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19: 41-47
Adamyan LV, Andreeva EN, Gasparyan SA, Gevorkyan MA, Grigoryan OR, Grineva EN, et al. Polycystic ovary syndrome in reproductive age (modern approaches to diagnosis and treatment). Clinical guidelines (treatment protocol). М., 2015. Russian (Адамян Л.В., Андреева Е.Н., Гаспарян С.А., Геворкян М.А., Григорян О.Р., Гринева Е.Н. и др. Синдром поликистозных яичников в репродуктивном возрасте (современные подходы к диагностике и лечению). Клинические рекомендации (протокол лечения). М., 2015.) https://elibrary.ru/item.asp?id = 26714379
Bani Mohammad M, Majdi Seghinsara A. Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria and AMH. Endocr Rev. 2017; 18(1): 17-21. https://doi.org/10.22034/APJCP.2017.18.1.17
Gogoladze IN, Fedorova AI. Polycystic ovary syndrome in the practice of a teenage gynecologist: the possibility of prevention, the principles of therapy. Gynecology. 2017; 19(2): 23-27. Russian (Гоготадзе И.Н., Федорова А.И. Синдром поликистозных яичников в практике подросткового гинеколога: возможности профилактики, принципы терапии //Гинекология. 2017. Т. 19, № 2. С. 23-27)
Dubrovina SO. Polycystic ovarian syndrome: a modern overview. Gynecology. 2016; 18(5): 14-17. Russian (Дубровина С.О. Синдром поликистозных яичников: современный обзор //Гинекология. 2016. Т. 18, № 5. С. 14-17)
Khashchenko EP, Uvarova EV, Mamedova FSh. Phenotypic features of polycystic ovary syndrom in adolescent girls. Pediatric and adolescent reproductive health. 2017; 1: 37-50. Russian (Хащенко Е.П., Уварова Е.В., Мамедова Ф.Ш. Фенотипические особенности синдрома поликистозных яичников у девочек подросткового возраста //Репродуктивное здоровье детей и подростков. 2017. № 1. С. 37-50)
Elgina S, Artymuk N, Вeglova A. Indicators of an ovarian reserve in women of early reproductive age with PCOS depending on the phenotype. Hormone Molecular Biology and Clinical In vestigation. 2019; 39(3): 20180081. https://doi.org/10.1515/hmbci-2018-008
Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016; 106(1): 6-15. https://doi. org/10.1016/j.fertnstert.2016.05.003
Bedrick BS, Eskew AM, Chavarro JE, Jungheim ES. Self-Administered Questionnaire to Screen for Polycystic Ovarian Syndrome. Womens Health Rep (New Rochelle). 2020; 1(1): 566-573. doi: 10.1089/whr.2020.0073
http://prevention.nih.gov/workshops/2012/pcos/docs/FinalReport.pdf
Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American association of clinical endocrinologists, American college of endocrinology, and Androgen excess and PCOS society disease state clinical review: guide to the best practices in the evalution and treatment of polycyctic ovary syndrome – part 1. Endocr Pract. 2015; 21(11): 1291-1300. doi: 10.4158/EP15748.DSC
Randeva HS, Tan BK, Weickert MO, et al. Cardiometabolic aspects of the poly-cystic ovary syndrome. Endocr Rev. 2012; 33: 812
Beglova AY, Elgina SI. Ovarian reserve in women of reproductive age with polycystic ovary syndrome depending on the phenotype. Mother and Baby in Kuzbass. 2018; 3(74): 27-30. Russian (Беглова А.Ю., Елгина С.И. Овариальный резерв у женщин репродуктивного возраста с синдромом поликистозных яичников в зависимости от фенотипа //Мать и Дитя в Кузбассе. 2018. № 3(74). С. 27-30)
Wongwananuruk T, Panichyawat N, Indhavivadhana S, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, et al. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women. Taiwan J Obstet Gynecol. 2018; 57(4): 499-506. doi: 10.1016/j.tjog.2018.06.004
Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome. Hum Reprod. 2017; 32(8): 1716-1722. doi: 10.1093/humrep/dex239
Ibragimov BF, Hudoyarova DR. Modern methods of diagnostics of hyperandrogenic conditions in gynecology. Achievements of Science and Education. 2019; 10(51): 69-73. Russian (Ибрагимов Б.Ф., Худоярова Д.Р. Современные методы диагностики гиперандрогенных состояний в гинекологии //Достижения науки и образования. 2019. № 10(51). С. 69-73)
Romualdi D, Di Florio C, Tagliaferri V, De Cicco S, Gagliano D, Immediata V, et al. The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes. Reprod Sci. 2016; 23(5): 655-661. https://doi.org/10.1177/1933719115611751
Prilepskaya VN, Ovsyannikova TV. Gynecological endocrinology. 3nd ed. М., 2015. Russian (Прилепская В.Н., Овсянникова Т.В. Гинекологическая эндокринология. 3-е изд. М., 2015)
Lie Fong S, Laven JSE, Duhamel A, Dewailly D. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis. Hum Reprod. 2017; 32(8): 1723-1731. doi: 10.1093/humrep/dex226
Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014; 171(4): 1-29. doi: 10.1530/EJE-14-0253